Literature DB >> 26045309

Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.

Yin J Chen1, Bedda L Rosario2, Wenzhu Mowrey2, Charles M Laymon1, Xueling Lu1, Oscar L Lopez3, William E Klunk4, Brian J Lopresti1, Chester A Mathis1, Julie C Price5.   

Abstract

UNLABELLED: The primary goal of this study was to assess the suitability of (11)C-Pittsburgh compound B ((11)C-PiB) blood-brain barrier delivery (K1) and relative delivery (R1) parameters as surrogate indices of cerebral blood flow (CBF), with a secondary goal of directly examining the extent to which simplified uptake measures of (11)C-PiB retention (amyloid-β load) may be influenced by CBF, in a cohort of controls and patients with mild cognitive impairment (MCI) and Alzheimer disease (AD).
METHODS: Nineteen participants (6 controls, 5 AD, 8 MCI) underwent MR imaging, (15)O-water PET, and (11)C-PiB PET in a single session. Fourteen regions of interest (including cerebellar reference region) were defined on MR imaging and applied to dynamic coregistered PET to generate time-activity curves. Multiple analysis approaches provided regional (15)O-water and (11)C-PiB measures of delivery and (11)C-PiB retention that included compartmental modeling distribution volume ratio (DVR), arterial- and reference-based Logan DVR, simplified reference tissue modeling 2 (SRTM2) DVR, and standardized uptake value ratios. Spearman correlation was performed among delivery measures (i.e., (15)O-water K1 and (11)C-PiB K1, relative K1 normalized to cerebellum [Rel-K1-Water and Rel-K1-PiB], and (11)C-PiB SRTM2-R1) and between delivery measures and (11)C-PiB retention, using the Bonferroni method for multiple-comparison correction.
RESULTS: Primary analysis showed positive correlations (ρ ≈0.2-0.5) between (15)O-water K1 and (11)C-PiB K1 that did not survive Bonferroni adjustment. Significant positive correlations were found between Rel-K1-Water and Rel-K1-PiB and between Rel-K1-Water and (11)C-PiB SRTM2-R1 (ρ ≈0.5-0.8, P < 0.0036) across primary cortical regions. Secondary analysis showed few significant correlations between (11)C-PiB retention and relative (11)C-PiB delivery measures (but not (15)O-water delivery measures) in primary cortical areas that arose only after accounting for cerebrospinal fluid dilution.
CONCLUSION: (11)C-PiB SRTM2-R1 is highly correlated with regional relative CBF, as measured by (15)O-water K1 normalized to cerebellum, and cross-sectional (11)C-PiB retention did not strongly depend on CBF across primary cortical regions. These results provide further support for potential dual-imaging assessments of regional brain status (i.e., amyloid-β load and relative CBF) through dynamic (11)C-PiB imaging.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  Alzheimer’s disease; PiB PET; amyloid; blood flow; kinetic modeling

Mesh:

Substances:

Year:  2015        PMID: 26045309      PMCID: PMC4730871          DOI: 10.2967/jnumed.114.152405

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

2.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 3.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

Review 4.  Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM.

Authors:  Mark Slifstein
Journal:  J Nucl Med       Date:  2008-02       Impact factor: 10.057

Review 5.  Update on amyloid imaging: from healthy aging to Alzheimer's disease.

Authors:  David A Wolk; William Klunk
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

6.  Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.

Authors:  Philipp T Meyer; Sabine Hellwig; Florian Amtage; Christof Rottenburger; Ursula Sahm; Peter Reuland; Wolfgang A Weber; Michael Hüll
Journal:  J Nucl Med       Date:  2011-02-14       Impact factor: 10.057

7.  Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease.

Authors:  Nelleke Tolboom; Maqsood Yaqub; Ronald Boellaard; Gert Luurtsema; Albert D Windhorst; Philip Scheltens; Adriaan A Lammertsma; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

8.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

9.  Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.

Authors:  Rebecca L McNamee; Seong-Hwan Yee; Julie C Price; William E Klunk; Bedda Rosario; Lisa Weissfeld; Scott Ziolko; Michael Berginc; Brian Lopresti; Steven Dekosky; Chester A Mathis
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

10.  Frequent amyloid deposition without significant cognitive impairment among the elderly.

Authors:  Howard Jay Aizenstein; Robert D Nebes; Judith A Saxton; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Scott K Ziolko; Jeffrey A James; Beth E Snitz; Patricia R Houck; Wenzhu Bi; Ann D Cohen; Brian J Lopresti; Steven T DeKosky; Edythe M Halligan; William E Klunk
Journal:  Arch Neurol       Date:  2008-11
View more
  31 in total

1.  Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures.

Authors:  Laura L Boles Ponto; David J Moser; Yusuf Menda; Emily L Harlynn; Sean D DeVries; Jacob J Oleson; Vincent A Magnotta; Susan K Schultz
Journal:  J Neuroimaging       Date:  2018-11-21       Impact factor: 2.486

2.  Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Authors:  Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2019-01-10       Impact factor: 4.673

3.  Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging.

Authors:  Murat Bilgel; Lori Beason-Held; Yang An; Yun Zhou; Dean F Wong; Susan M Resnick
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-12       Impact factor: 6.200

4.  Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden.

Authors:  Janusch Blautzik; Matthias Brendel; Julia Sauerbeck; Sebastian Kotz; Franziska Scheiwein; Peter Bartenstein; John Seibyl; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-22       Impact factor: 9.236

Review 5.  Positron emission tomography in multiple sclerosis - straight to the target.

Authors:  Benedetta Bodini; Matteo Tonietto; Laura Airas; Bruno Stankoff
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

6.  [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease.

Authors:  Tharick A Pascoal; Mira Chamoun; Elad Lax; Hsiao-Ying Wey; Monica Shin; Kok Pin Ng; Min Su Kang; Sulantha Mathotaarachchi; Andrea L Benedet; Joseph Therriault; Firoza Z Lussier; Frederick A Schroeder; Jonathan M DuBois; Baileigh G Hightower; Tonya M Gilbert; Nicole R Zürcher; Changning Wang; Robert Hopewell; Mallar Chakravarty; Melissa Savard; Emilie Thomas; Sara Mohaddes; Sarah Farzin; Alyssa Salaciak; Stephanie Tullo; A Claudio Cuello; Jean-Paul Soucy; Gassan Massarweh; Heungsun Hwang; Eliane Kobayashi; Bradley T Hyman; Bradford C Dickerson; Marie-Christine Guiot; Moshe Szyf; Serge Gauthier; Jacob M Hooker; Pedro Rosa-Neto
Journal:  Nat Commun       Date:  2022-07-19       Impact factor: 17.694

7.  Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an 18F-AV-45 study.

Authors:  Min Wang; Zhuangzhi Yan; Huiwei Zhang; Jiaying Lu; Ling Li; Jintai Yu; Jian Wang; Hiroshi Matsuda; Chuantao Zuo; Jiehui Jiang
Journal:  Quant Imaging Med Surg       Date:  2021-01

8.  Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies.

Authors:  Hayel Tuncel; Denise Visser; Maqsood Yaqub; Tessa Timmers; Emma E Wolters; Rik Ossenkoppele; Wiesje M van der Flier; Bart N M van Berckel; Ronald Boellaard; Sandeep S V Golla
Journal:  Mol Imaging Biol       Date:  2021-01-26       Impact factor: 3.488

9.  Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures.

Authors:  Fabio Raman; Yu-Hua Dean Fang; Sameera Grandhi; Charles F Murchison; Richard E Kennedy; John C Morris; Parinaz Massoumzadeh; Tammie Benzinger; Erik D Roberson; Jonathan McConathy
Journal:  J Nucl Med       Date:  2021-05-28       Impact factor: 10.057

10.  [11C]PBR28 radiotracer kinetics are not driven by alterations in cerebral blood flow.

Authors:  Christin Y Sander; Stefano Bovo; Angel Torrado-Carvajal; Daniel Albrecht; Hongping Deng; Vitaly Napadow; Julie C Price; Jacob M Hooker; Marco L Loggia
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.